BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33713731)

  • 1. Secondary substitutions in the hemagglutinin and neuraminidase genes associated with neuraminidase inhibitor resistance are rare in the Influenza Resistance Information Study (IRIS).
    Roosenhoff R; Schutten M; Reed V; Clinch B; van der Linden A; Fouchier RAM; Fraaij PLA
    Antiviral Res; 2021 May; 189():105060. PubMed ID: 33713731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study.
    Lina B; Boucher C; Osterhaus A; Monto AS; Schutten M; Whitley RJ; Nguyen-Van-Tam JS
    Influenza Other Respir Viruses; 2018 Mar; 12(2):267-278. PubMed ID: 29265727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
    Farrukee R; Gunalan V; Maurer-Stroh S; Reading PC; Hurt AC
    J Virol; 2022 Aug; 96(15):e0091822. PubMed ID: 35867563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
    Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan.
    Chong Y; Matsumoto S; Kang D; Ikematsu H
    Influenza Other Respir Viruses; 2019 Mar; 13(2):115-122. PubMed ID: 30548432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the Neuraminidase Amino Acid Sequences of Influenza A/H1N1pdm09, A/H3N2, and B Viruses Isolated from Influenza Patients in the 2013/14 Japanese Influenza Season].
    Ikematsu H; Chong Y; Shirane K; Toh H; Sasaki H; Koga Y; Matsumoto S; Hotta T; Uchiumi T; Kang D
    Fukuoka Igaku Zasshi; 2015 Aug; 106(8):231-9. PubMed ID: 26630841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
    Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
    Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS).
    Whitley RJ; Boucher CA; Lina B; Nguyen-Van-Tam JS; Osterhaus A; Schutten M; Monto AS
    Clin Infect Dis; 2013 May; 56(9):1197-205. PubMed ID: 23307766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.
    Pizzorno A; Abed Y; Plante PL; Carbonneau J; Baz M; Hamelin MÈ; Corbeil J; Boivin G
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6398-405. PubMed ID: 25114143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
    Marjuki H; Mishin VP; Chesnokov AP; De La Cruz JA; Davis CT; Villanueva JM; Fry AM; Gubareva LV
    J Virol; 2015 May; 89(10):5419-26. PubMed ID: 25740997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.
    Huang W; Li X; Cheng Y; Tan M; Guo J; Wei H; Zhao X; Lan Y; Xiao N; Wang Z; Wang D; Shu Y
    Virol J; 2015 Jun; 12():96. PubMed ID: 26103966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid discrimination of oseltamivir-resistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A/H1N1 2009 virus by duplex one-step RT-PCR assay.
    Nakauchi M; Ujike M; Obuchi M; Takashita E; Takayama I; Ejima M; Oba K; Konomi N; Odagiri T; Tashiro M; Kageyama T;
    J Med Virol; 2011 Jul; 83(7):1121-7. PubMed ID: 21567417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for antiviral resistance among influenza viruses circulating in Algeria during five consecutive influenza seasons (2009-2014).
    Ait-Aissa A; Derrar F; Hannoun D; Gradi EA; Scaravelli D; Bouslama Z
    J Med Virol; 2018 May; 90(5):844-853. PubMed ID: 29315673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
    Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
    PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.
    Franco-May DA; Gómez-Carballo J; Barrera-Badillo G; Cruz-Ortíz MN; Núñez-García TE; Arellano-Suárez DS; Wong-Arámbula C; López-Martínez I; Wong-Chew RM; Ayora-Talavera G
    Antiviral Res; 2024 Jul; 227():105918. PubMed ID: 38795911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
    Huang L; Zhou JF; Wei H; Shu YL
    Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment.
    Tamura D; Nguyen HT; Sleeman K; Levine M; Mishin VP; Yang H; Guo Z; Okomo-Adhiambo M; Xu X; Stevens J; Gubareva LV
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6141-6. PubMed ID: 24080660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.